Last reviewed · How we verify

NCT03876080: TDNDOMS

Dry Needling in Subjects With Delayed Onset Muscle Soreness

Completed NA Last updated 27 July 2023
What this trial tests

NA trial testing Dry needling in Delayed Onset Muscle Soreness in 36 participants. Completed in 23 May 2023.

Timeline
30 March 2019
Primary endpoint
23 May 2023
23 May 2023

Quick facts

Lead sponsorBradley University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment36
Start date30 March 2019
Primary completion23 May 2023
Estimated completion23 May 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Bradley University

Who can join

Adults 18 to 35, any sex, with Delayed Onset Muscle Soreness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the biomechanical response in delayed onset muscle soreness using dry needling vs. sham

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dry needling

Trials testing the same drug.

Other recruiting trials for Delayed Onset Muscle Soreness

Currently open trials in the same condition.

Other Bradley University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03876080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing